Literature DB >> 9773493

Heterogeneous cholinergic reactions of ringed seal coronary arteries.

R Elsner1, I S de la Lande.   

Abstract

Coronary blood flow of some seal species is unusual in that it is highly variable in both non-diving and diving conditions and shows intermittent fluctuations, especially during dives when it frequently ceases for brief periods. We sought regulatory mechanisms governing these reactions by studying isometric tension recordings of isolated left circumflex (LC) and left anterior descending (LAD) coronary arteries of ringed seals, Phoca hispida, during reactions to a variety of agents for stimulating or blocking autonomic responses of the vascular smooth muscle. Micromolar acetylcholine (ACh) produced constriction of the small diameter segments of the LAD, but relaxation of the LC and larger segments of LAD. Both constrictions and dilations were prevented by atropine. Small vessel constriction by ACh was prevented by micromolar indomethacin and by a thromboxane receptor antagonist. Large vessel ACh dilations were prevented or reduced by rubbing off the endothelium and by the L-arginine analog, L-NG-nitro-arginine, an inhibitor of nitric oxide synthesis. We conclude that cholinergic, muscarinic, dilation of ringed seal large coronary arteries is mediated by endothelial-derived relaxing factor (EDRF), whereas ACh constriction of small arteries is mediated by a prostaglandin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9773493     DOI: 10.1016/s1095-6433(98)00019-1

Source DB:  PubMed          Journal:  Comp Biochem Physiol A Mol Integr Physiol        ISSN: 1095-6433            Impact factor:   2.320


  1 in total

1.  Low guanylyl cyclase activity in Weddell seals: implications for peripheral vasoconstriction and perfusion of the brain during diving.

Authors:  Allyson G Hindle; Kaitlin N Allen; Annabelle J Batten; Luis A Hückstädt; Jason Turner-Maier; S Anne Schulberg; Jeremy Johnson; Elinor Karlsson; Kerstin Lindblad-Toh; Daniel P Costa; Donald B Bloch; Warren M Zapol; Emmanuel S Buys
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-03-20       Impact factor: 3.619

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.